This rise in CBD frequency may be due to the relaxation of CBD regulation, a growing interest in the use of cannabinoids for insomnia and sleep [35,36], and interest in the nonpsychoactive properties of CBD in comparison to other cannabinoids. Here, OPN1MW is linked to insomnia measurement.